Labiotech.eu

News and Trends 10 Nov 2016

Evotec chooses Oxford as Proving Ground for Academia-Industry Bridge

The German CRO has struck a deal with the University of Oxford to test a model framework for bringing academic research to the clinic faster. Evotec started out as a service provider in Hamburg, but thanks to former CEO Jörn Aldag, it has blossomed into a company that specializes in transforming newly discovered therapies into […]

November 10, 2016 - 3 minutesmins - By Evelyn Warner

News and Trends 10 Nov 2016

European Biotech is working hard to Beat back Melanoma

Immunocore and Pierre Fabre have been representing Europe in this years’ Society for Melanoma Research Congress. This type of cancer may have its days counted! This week, scientists from around the globe met at the MRC to get an update on what’s going on in the fights against melanoma, the least common but most deadly skin […]

November 10, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Nov 2016

This has been the Worst Financial Year for Biotech in a Decade

A presentation on the financial state of biotech kicked off BIO-Europe in Cologne this week. The hostile American political climate has done some damage. There’s a political storm brewing across the Atlantic that has everyone in biotech worried: what does the American political climate mean for the future of the industry? The numbers already look […]

November 10, 2016 - 4 minutesmins - By Evelyn Warner

News and Trends 9 Nov 2016

British Artificial Intelligence will soon run Clinical Trials

Artificial Intelligence can make clinical trials cheaper and faster, and this British start-up is about to start testing its technology to optimize drug development. BenevolentAI is a London start-up that specializes in artificial intelligence (AI); its BenevolentBio division, formerly Stratified Medical, applies AI to human health and biotech. Its baby is a technology that could speed […]

November 9, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 9 Nov 2016

Up, up and away! CureVac’s money pile now Totals €325M

CureVac has raised an additional €27M ($29.5M) that will help the company keep on its track to be the first one to launch a mRNA therapy, a technology that can revolutionize how drugs are designed. CureVac is a German company in the billion-euro biotech club at the forefront of messenger RNA (mRNA) therapies, a technology that […]

November 9, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

patrimonio designs ltd trump clinton small

News and Trends 9 Nov 2016

UPDATE: The US did the unthinkable. What does this mean for European Biotech?

Donald Trump, a reality TV host, has just beaten Hillary Clinton, whose qualifications are too many to list, to become President of the United States. Who knows what’s next for European biotech? The world is preparing its nuclear fallout shelters, and biotech might best follow suit. The Donald is not known for his coherence, consistency […]

November 9, 2016 - 5 minutesmins - By Evelyn Warner

News and Trends 8 Nov 2016

These companies want to use Stem Cells to improve Drug Safety

Axiogenesis and Metrion Biosciences will use stem cells to improve preclinical neurotoxicity and cardiac safety testing, a feat that can significantly reduce the time and cost of drug discovery and clinical development. Axiogenesis is a Biotech from Cologne, Germany, that develops cell lines derived from induced pluripotent stem cells (iPSCs) for preclinical applications. The company […]

November 8, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 8 Nov 2016

Has Gender Diversity in Biotech changed? “No”, says Managing partner of Sofinnova #BIOEurope

In our second interview of BIO-Europe, we talked about gender diversity with Rafaèle Tordjman, one of the managing partners of Sofinnova Partners, a top Biotech VC in Europe. She has been very active in making biotech more open to women, and I wanted to know more about her analysis of the situation. I had met […]

November 8, 2016 - 1 minutemin - By Philip Hemme

News and Trends 8 Nov 2016

Swiss SynBio adds CRISPR to its Toolkit for new Specialty Chemicals

Evolva is licensing the CRISPR patents of Emmanuelle Charpentier, in a deal with holding company ERS Genomics. This will grant access to the wonder gene-editing technology for one of the most important players in European SynBio. Headquartered in Switzerland, Evolva develops new ways to obtain ingredients and specialty chemicals with brewing and engineered microorganisms. Its […]

November 8, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 7 Nov 2016

Catching Up with the French Leader in Immuno-Oncology #BIOEurope

Despite the deflating attitudes towards immuno-oncology, OSE Immunotherapeutics is forging ahead. We caught up with the CEO, Dominique Costantini, at BIO Europe to make our first video Interview. OSE Immunotherapeutics is developing immunotherapy products against invasive and metastatic late-stage cancers. Memopi is one of its key technologies, and it is currently under development for ovarian, colon and breast […]

November 7, 2016 - 1 minutemin - By Philip Hemme

News and Trends 7 Nov 2016

Green Light for Genfit to Tackle another Liver Disease

The FDA has cleared Genfit’s IND application to treat a second liver disease with a big unmet clinical need. With this new step forward, the company gets even closer to become the leader in liver disease treatments. After a very successful fundraising last week, Genfit is kicking off the week with good news from the […]

November 7, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 7 Nov 2016

Results from 45% of Clinical Trials are kept Secret

A new transparency study has identified Sanofi, Novartis and GSK as the companies that keep the most clinical trial results unreported. TrialsTracker is a tool developed at the University of Oxford that automatically rates transparency on clinical trials by checking if there are results available in clinicaltrials.gov and PubMed. The results: globally, 45% of data on […]

November 7, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Evotec chooses Oxford as Proving Ground for Academia-Industry Bridge

European Biotech is working hard to Beat back Melanoma

This has been the Worst Financial Year for Biotech in a Decade

British Artificial Intelligence will soon run Clinical Trials

Up, up and away! CureVac’s money pile now Totals €325M

UPDATE: The US did the unthinkable. What does this mean for European Biotech?

These companies want to use Stem Cells to improve Drug Safety

Has Gender Diversity in Biotech changed? “No”, says Managing partner of Sofinnova #BIOEurope

Swiss SynBio adds CRISPR to its Toolkit for new Specialty Chemicals

Catching Up with the French Leader in Immuno-Oncology #BIOEurope

Green Light for Genfit to Tackle another Liver Disease

Results from 45% of Clinical Trials are kept Secret

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!